WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

A ALIMENTARY TRACT AND METABOLISM
A12 MINERAL SUPPLEMENTS

This group contains mineral supplements used for treatment of mineral deficiency. Magnesium carbonate used for treatment of mineral deficiency is classified in A02AA01.


A12B POTASSIUM
A12BA Potassium

This group comprises preparations used as potassium supplements.

This group comprises also all combined potassium preparations used in the treatment of potassium deficiency conditions.

Small non-therapeutic amounts of potassium hydrogencarbonate are allowed at each level of plain potassium salts.
Potassium, combinations with other drugs, are classified at separate 5th levels using the corresponding 50-series.
Diuretics and potassium in combination, see C03 - Diuretics.

See also B05 - Blood substitutes and perfusion solutions.



The DDDs are based on treatment of potassium deficiency and correspond to a potassium content of about 40 mmol potassium.


List of abbreviations

Last updated: 2013-12-19